The potential use of selective 5-HT2C agonists in treating obesity.

The potential use of selective 5-HT2C agonists in treating obesity.

Item
http://www.wikidata.org/entity/Q34497896
Switching from serotonin reuptake inhibitors to agomelatine in patients with refractory obsessive-compulsive disorder: a 3 month follow-up case seriesSerotonergic drugs and valvular heart diseasePharmacological targeting of the serotonergic system for the treatment of obesityPharmacological characterization of an antisense knockdown zebrafish model of Dravet syndrome: inhibition of epileptic seizures by the serotonin agonist fenfluramineDesign and Synthesis of (2-(5-Chloro-2,2-dimethyl-2,3-dihydrobenzofuran-7-yl)cyclopropyl)methanamine as a Selective Serotonin 2C Agonist.Optimization of 2-phenylcyclopropylmethylamines as selective serotonin 2C receptor agonists and their evaluation as potential antipsychotic agents.Appetite suppressants, cardiac valve disease and combination pharmacotherapyPharmacologic management of obesity.Discovery and development of 5-HT(₂C) receptor agonists for obesity: is there light at the end of the tunnel?Evidence of complex involvement of serotonergic genes with restrictive and binge purge subtypes of anorexia nervosa.Regioselective alkylation of 1,3,4,5-tetrahydrobenzo[d]azepin-2-one and biological evaluation of the resulting alkylated products as potentially selective [Formula: see text] agonists.Reducing Effect of Saikosaponin A, an Active Ingredient of , on Intake of Highly Palatable Food in a Rat Model of Overeating
P2860

The potential use of selective 5-HT2C agonists in treating obesity.

Item
http://www.wikidata.org/entity/Q34497896
description
2006 nî lūn-bûn
@nan
2006 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մարտին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
The potential use of selective 5-HT2C agonists in treating obesity.
@ast
The potential use of selective 5-HT2C agonists in treating obesity.
@en
The potential use of selective 5-HT2C agonists in treating obesity.
@nl
type
label
The potential use of selective 5-HT2C agonists in treating obesity.
@ast
The potential use of selective 5-HT2C agonists in treating obesity.
@en
The potential use of selective 5-HT2C agonists in treating obesity.
@nl
prefLabel
The potential use of selective 5-HT2C agonists in treating obesity.
@ast
The potential use of selective 5-HT2C agonists in treating obesity.
@en
The potential use of selective 5-HT2C agonists in treating obesity.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P921
P356
P1433
P1476
The potential use of selective 5-HT2C agonists in treating obesity.
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P921